| Source publication date | (updated; first published 2026-03-30) |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Consumer health outlet |
| Population | Women |
| Source | TreatCompare |
| URL | treatcompare.com/articles/testosterone-for-women-uk (opens in a new tab) |
Specific Claim Evaluated
Testosterone is prescribed as part of menopausal HRT mainly for low libido, fatigue and brain fog, in line with British Menopause Society guidance, and side effects such as acne, facial hair growth and voice deepening are rare when properly dosed and monitored.
Primary Research Supporting or Contradicting the Claim
Randomized trials at physiologic doses show more acne and hair growth with testosterone than placebo (Islam et al., 2019). Evidence is insufficient to establish an effect on cognition (Faulkner et al., 2026), and the only evidence-based indication is hypoactive sexual desire disorder (Davis et al., 2019).
Corrected Evidence-Based Interpretation
UK guidance supports testosterone for low sexual desire after HRT optimization. It is not indicated for fatigue or brain fog, and androgenic adverse effects are more common than with placebo even at physiologic doses.
Rationale for Grade
The page cites guidance limited to low sexual desire but presents fatigue and brain fog as main indications, and it describes androgenic adverse effects as rare without evidence. Both statements misrepresent the sources they rely on.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD." - Faulkner A, Desai R, Keay N, Ellahi SA, Spector A. Testosterone therapy for cognition in menopause: a systematic review and meta-analysis. Reprod Fertil. 2026;7(4). PMID
Supporting excerpt: "insufficient to establish an effect rather than as evidence of no effect" - Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754-766. PMID
Supporting excerpt: "Testosterone is effective for postmenopausal women with low sexual desire causing distress"